Precision Medicine is an emerging approach in health promotion and improvement of the healthcare model, diagnosis, prevention, and treatment of diseases taking into account the variability in genes for each person. Genetic sequencing is an important tool that helps physicians define the best care strategy for their patients. In a hybrid format (presential and online), this event will have the participation of experts from the Clinical Staff of Hospital Israelita Albert Einstein and City Of Hope, one of the main independent centers in the world in the study and treatment of cancer, besides other international speakers.
Why should I participate?
The second edition of the event will include an exclusive day dedicated to understanding the relevance and application of genetics in oncology, another day dedicated to precision medicine in hemato-oncology and the last day devoted to innovating in clinical and analytical practice. It will also feature national and international speakers who are leading players in personalized medicine in Brazil and worldwide. Register now, this event was especially designed for you!
Check out some of the highlights that make the II EINSTEIN INTERNATIONAL SYMPOSIUM ON PRECISION MEDICINE an event not to be missed!
FIRST EXCLUSIVE DAY ON GENOMICS AND ONCOGENETICS
SECOND DAY DEDICATED TO INNOVATIONS IN HEMATO ONCOLOGY
DAY THREE REVOLUTIONIZING CLINICAL PRACTICE AND HEALTHCARE ANALYTICS
NATIONAL AND INTERNATIONAL SPEAKERS
FACE-TO-FACE AND INTERACTIVE QUESTIONS & ANSWERS SESSION
FACE-TO-FACE AND ONLINE TRANSMISSION WITH CERTIFICATE
THIS EVENT IS FOR YOU!
Tailored for healthcare professionals, interested in innovations in medicine and skilled with healthcare data with a degree in the following courses:
- Medicine
- Biomedicine
- Nursing
- Pharmacy
- Biology
- Data Science
- Health researchers or academics
PROGRAMMING
Time
Activity
Moderator/Speaker
08:00 am – 08:15 am
Opening Session
Miguel Cendoroglo – Hospital Israelita Albert Einstein
TUMOR GENOMICS
João Bosco de Oliveira – Hospital Israelita Albert Einstein
08:15 am – 08:35 am
Tumor genomics in clinical practice
Paulo Campregher – Hospital Israelita Albert Einstein
08:35 am – 08:45 am
Discussion
Paulo Campregher e João Bosco de Oliveira – Hospital Israelita Albert Einstein
GENOMICS IN PRECISION MEDICINE
João Bosco de Oliveira Filho – Hospital Israelita Albert Einstein
08:45 am – 09:15 am
Genomic and data sharing approaches to uplift discovery in rare disease
Anne O´Donnel – Boston Children’s Hospital and Broad Institute of MIT and Harvard
09:15 am – 09:45 am
Multiomics in the study of rare diseases
João Bosco de Oliveira Filho –Hospital Israelita Albert Einstein
09:45 am – 09:55 am
Discussion
João Bosco de Oliveira Filho e Anne O´Donnel
09:55 am- 10:25 am
BREAK
LIQUID BIOPSY
João Bosco de Oliveira Filho – Hospital Israelita Albert Einstein
10:25 am – 10:40 am
New strategies for cancer screening using liquid biopsy
Alessandro Igor Cavalcanti Leal – Delfi Diagnostics
10:40 am – 10:55 am
Liquid Biopsy
Fernando Moura Silva –Hospital Israelita Albert Einstein
GENOMICS IN PRECISION MEDICINE
João Bosco de Oliveira Filho – Hospital Israelita Albert Einstein
10:55 am – 11:20 am
Universal genomic newborn sequencing?
Robert Green – Harvard Medical School
11:20 am – 11:45 am
CRISPR gene therapy for sickle cell disease
Ricardo Weinlich – Instituto de Ensino e Pesquisa Hospital Israelita Albert Einstein
11:45 am – 12:00 am
Discussion
João Bosco de Oliveira Filho, Robert Green e Ricardo Weinlich
12:00 pm – 12:30 pm
Satellite symposium Astra Zeneca: Precision Medicine in Lung Cancer
Fernando Moura – Hospital Israelita Albert Einstein
12:30 pm – 13:00 pm
BREAK
PHARMACOGENOMICS
João Bosco de Oliveira Filho – Hospital Israelita Albert Einstein
01:00 pm – 01:20 pm
Pharmacogenomics
Luis Izquierdo López – Veritas Genetics
CITY OF HOPE
Alessandro Igor Cavalcanti Leal – Delfi Diagnostics
Fernanda Teresa Lima – Hospital Israelita Albert Einstein
01:20 pm – 01:40 pm
Communicating Genomic Information to Patients & Providers
Stacy W. Gray – City of Hope
01:40 pm – 02:00 pm
Integrating Somatic and Germline Testing for Precision Medicine
Stephen Gruber – City of Hope
02:00 pm – 02:20 pm
Discussion
Alessandro Leal, Stacy W. Gray e Stephen Gruber
HEREDITARY PREDISPOSITION TO CANCER
Fernanda Teresa Lima – Hospital Israelita Albert Einstein
02:20 pm – 02:35 pm
Hereditary pancreatic cancer
Pedro Luiz Serrano Uson Junior – Hospital Israelita Albert Einstein
02:35 pm – 02:50 pm
Lynch syndrome
Stephen Gruber – City of Hope
02:50 pm – 03:05 pm
Ten Genes for Breast Cancer
William Foulkes – McGill University
03:05 pm – 03:20 pm
Hereditary gastric cancer – updates
Carla Oliveira – Bioinf2bio LDA
03:20 pm – 03:35 pm
Discussion
Fernanda Teresa Lima, Carla Oliveira, Stephen Gruber, Willian Foulkes e Pedro Luiz Serrano Uson Junior
03:35 pm – 04:05 pm
BREAK
PRACTICE IN GENOMIC MEDICINE
Fernanda Teresa Lima – Hospital Israelita Albert Einstein
04:05 pm – 04:20 pm
Genomic medicine skills and competencies
Dhavendra Kumar – William Harvey Research Institute, Bart’s &. The London School of Medicine & Dentistry, Queen Mary University of London, UK
04:20 pm – 04:50 pm
Genomics and Society: Ethical, Legal, Cultural and Socioeconomic Implications
Dhavendra Kumar – William Harvey Research Institute, Bart’s &. The London School of Medicine & Dentistry, Queen Mary University of London, UK
04:50 pm – 05:05 pm
Discussion
Fernanda Teresa Lima e Dhavendra Kuma
GENOMIC MEDICINE IN PEDIATRICS
Fernanda Teresa Lima – Hospital Israelita Albert Einstein
05:05 pm – 05:20 pm
Mutation-specific therapies – the case of cystic fibrosis
Luiz Vicente Ribeiro Ferreira da Silva Filho –Hospital Israelita Albert Einstein
05:20 pm – 05:35 pm
Precision medicine in pediatric sepsis
Eduardo Juan Troster – Hospital Israelita Albert Einstein
05:35 pm – 05:50 pm
Genomic Medicine in Fetal Medicine
Rita de Cassia Sanchez e Oliveira –Hospital Israelita Albert Einstein
05:50 pm – 06:05 pm
Genomic Neonatal Screening: Where are we and where are we going?
Flavia Balbo Piazzon
06:05 pm – 06:20 pm
Discussion
Fernanda Teresa Lima, Luiz Vicente Ribeiro Ferreira da Silva Filho, Eduardo Juan Troster, Rita de Cassia Sanchez e Oliveira e Flávia Balbo Piazzon
06:20 – pm
Closing Remarks
Time
Activity
Moderator/Speaker
CT-DNA in cancer recurrence
Juliana Beal – Hospital Israelita Albert Einstein
08:15 am – 08:30 am
Use of CT-DNA for personalized cancer recurrence testing
Dra. Tiffany Ellis – Natera
ROBOTIC SURGERY
Nam Jin Kim – Hospital Israelita Albert Einstein
08:30 am – 08:45 am
Robotic oncourologic surgery
José Roberto Colombro Junior – Hospital Israelita Albert Einstein
08:45 am – 09:00 am
Robotic oncothoracic surgery
Ricardo Mingarini Terra – Hospital Israelita Albert Einstein
09:00 am – 09:15 am
Robotic oncogynecologic surgery
Renato Moretti Marques – Hospital Israelita Albert Einstein
09:15 am – 09:30 am
Robotic oncogastrointestinal surgery
Sérgio Eduardo Alonso de Araújo – Hospital Israelita Albert Einstein
09:30 am – 09:45 am
Discussion
Nam Jin Kim, José Roberto Colombro Junior, Ricardo Mingarini Terra, Renato Moretti Marques e Sérgio Eduardo Alonso De Araújo
ONCOLOGICAL INTERVENTION AND DIAGNOSTIC MOLECULAR IMAGING
Francisco Leonardo Galastri – Hospital Israelita Albert Einstein
09:45 am – 10:00 am
Interventional radiology in the diagnosis of neoplasms
Guilherme Moratti Gilberto – Hospital Israelita Albert Einstein
10:00 am – 10:15 am
Molecular imaging diagnostic
Guilherme de Carvalho Campos Neto – Hospital Israelita Albert Einstein
10:15 am – 10:30 am
Discussion
Guilherme Moratti Gilberto, Guilherme De Carvalho Campos Neto, Francisco Leonardo Galastri e Fernando Moura
10:30 am – 11:00 am
BREAK
PRECISION MEDICINE IN ONCOTHORACIC AND BREAST
Juliana Beal – Hospital Israelita Albert Einstein
Fernando Moura Silva – Hospital Israelita Albert Einstein
11:00 am – 11:15 am
Precision medicine in lung cancer with molecular changes in EGFR and ALK
Patrícia Taranto – Hospital Israelita Albert Einstein
11:15 am – 11:30 am
Precision medicine in lung cancer: other molecular changes
Fernando Moura Silva – Hospital Israelita Albert Einstein
11:30 am – 11:45 am
The revolution of ADCS in breast cancer
Rafael Aliosha Kaliks Guendelmann – Hospital Israelita Albert Einstein
11:45 am – 12:00 pm
CTDNA in breast cancer: where are we?
Alessandro Igor Cavalcanti Leal – Delfi Diagnostics
12:00 pm – 12:15 pm
Discussion
Fernando Moura Silva, Rafael Aliosha Kaliks Guendelmanns e Alessandro Igor Cavalcanti Leal
12:15 pm – 12:45 pm
Satellite Symposium Roche: Personalized Healthcare in Early Stage Non-Small Cell Lung Cancer
Gustavo Schwartzman – Hospital Israelita Albert Einstein
12:45 pm – 01:15 pm
BREAK
PRECISION MEDICINE IN HEMATOLOGY
Nelson Hamerschlak – Hospital Israelita Albert Einstein
01:15 pm – 01:30 pm
Multiple myeloma
Mariana Nassif Kerbauy – Hospital Israelita Albert Einstein
01:30 pm – 01:45 pm
Lymphomas
Guilherme Fleury Perini – Hospital Israelita Albert Einstein
01:45 pm – 02:00 pm
Myeloide diseases
Fábio Pires de Souza Santos – Hospital Israelita Albert Einstein
02:00 pm – 02:15 pm
Bone marrow transplantation
Andreza Alice Feitosa Ribeiro – Hospital Israelita Albert Einstein
02:15 pm – 02:30 pm
Discussion
Nelson Hamerschlak, Mariana Nassif Kerbauy, Guilherme Fleury Perini, Fábio Pires de Souza Santos e Andreza Alice Feitosa Ribeiro
PRECISION MEDICINE IN ONCOGASTROENTEROLOGY, MELANOMA AND AGNOSTIC THERAPIES
Pedro Luiz Serrano Uson Junior – Hospital Israelita Albert Einstein
02:30 pm – 02:45 pm
Precision medicine in melanoma
Gustavo Schvartsman – Hospital Israelita Albert Einstein
02:45 pm – 03:00 pm
Development of biomarker-directed tissue-agnostic drugs
Roberto Carmagnani Pestana – Hospital Israelita Albert Einstein
03:00 pm – 03:15 pm
Precision medicine in colorectal cancer
Pedro Luiz Serrano Uson Junior – Hospital Israelita Albert Einstein
03:15 pm – 03:35 pm
Precision medicine in digestive system tumors
Tanios S. Bekaii-Saab – Mayo Clinic (ASCO)
03:30 pm – 03:50 pm
Discussion
Roberto Carmagnani Pestana, Gustavo Schwartzman, Pedro Luiz Serrano Uson Junior e Tanios S. Bekaii-Saab
03:50 pm – 04:20 pm
BREAK
PRECISION MEDICINE IN URO AND ONCOGYNECOLOGY
Fernando Cotait Maluf – Hospital Israelita Albert Einstein
Fernando Moura Silva – Hospital Israelita Albert Einstein
Oren Smaletz – Hospital Israelita Albert Einstein
04:20 pm – 04:40 pm
Precision medicine in prostate cancer
Oren Smaletz – Hospital Israelita Albert Einstein
04:40 pm – 04:55 pm
PET-PSMA indications
Marcelo Livorsi da Cunha – Hospital Israelita Albert Einstein
05:10 pm – 05:25 pm
Discussion
Oren Smaletz, Fernando Moura e Marcelo Livorsi da Cunha
Precision Medicine In Oncogynecology
Juliana Beal
05:10 pm – 05:25 pm
Precision medicine in oncoginecology
Donato Callegaro Filho
RADIOTHERAPY, THERAPEUTIC ONCOLOGICAL INTERVENTION AND THERANOSTIC
Fernando Moura Silva – Hospital Israelita Albert Einstein
05:25 pm – 05:40 pm
Precision radiotherapy
Eduardo Weltman – Hospital Israelita Albert Einstein
05:40 pm – 05:55 pm
Interventional radiology in the therapeutic approach to neoplastic lesions
Adalberto Batalha Megale – Hospital Israelita Albert Einstein
05:55 pm – 06:10 pm
Teranotic molecular image
Lilian Yuri Itaya Yamaga – Hospital Israelita Albert Einstein
06:10 pm – 06:25 pm
Discussion
Eduardo Weltman, Fernando Moura Silva, Adalberto Batalha Megale e Lilian Yuri Itaya Yamaga
06:25 – pm
Closing Remarks
Time
Activity
Moderator/Speaker
Pathology and Precision Medicine
Juliana Beal – Hospital Israelita Albert Einstein
08:15 am – 08:30 am
Pathology and Precision Medicine
Henrique Moura De Paula – Hospital Israelita Albert Einstein
CELL AND GENE THERAPY
José Mauro Kutner – Hospital Israelita Albert Einstein
08:30 am – 08:45 am
Main studies in cell and gene therapy in development at HIAE
José Mauro Kutner – Hospital Israelita Albert Einstein
08:45 am – 09:00 am
The therapeutic potential of extracellular vesicles in the treatment of intervertebral disc degeneration
Pedro Henrique Isoldi Pohl – Hospital Israelita Albert Einstein
09:00 am – 09:15 am
Gene therapy
Linus Pauling Fascina – Hospital Israelita Albert Einstein
09:15 am – 09:30 am
Car-Nk cell therapy
Lucila Nassif Kerbauy – Hospital Israelita Albert Einstein
09:30 am – 09:45 am
Discussion
José Mauro Kutner, Mário Lenza, Linus Pauling Fascina, Lucila Nassif Kerbauy e Pedro Henrique Isoldi Pohl
Metagenomics
Juliana Beal – Hospital Israelita Albert Einstein
09:45am – 10:00am
Liquor Precision Medicine
Gustavo Bruniera Peres Fernandes – Hospital Israelita Albert Einstein
10:00am – 10:15am
BREAK
IMMUNOTHERAPY
Kenneth J Gollob
10:15 am – 10:30 am
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with Anti-Pd-1
John Anthony McCulloch – National Institutes of Health, National Cancer Institute, Bethesda, USA
10:30 am – 10:45 am
Systemic immunological biomarkers determining the benefits of checkpoint inhibitor therapy
Kenneth J Gollob – Hospital Israelita Albert Einstein
10:45 am – 11:00 am
Tumor Mutation Burden as biomarker for immunotherapy in Non-small Cell Lung Cancer
Vamsi Velcheti – NYU Grossman School of Medicine
11:00 am – 11:15 am
Discussion
Kenneth J Gollob, John Mcculloch e Vamsi Velcheti
CARDIO AND NEUROGENETICS
Marcelo Franken – Hospital Israelita Albert Einstein
José Eduardo Krieger – Hospital Israelita Albert Einstein
11:15 am – 11:30 am
When to “think genetic testing” in dyslipidemic patients?
Fernando Rabioglio Giugni – InCor HC-FMUSP
11:30 am – 11:45 am
When do rhythm disorders and cardiomyopathies meet and which genetic tests should be considered?
Natália Olivetti – InCor HC-FMUSP
11:45 am – 12:00 pm
How to proceed if the result of the genetic test is a VUS?
José Luiz Pedroso – Hospital Israelita Albert Einstein
12:00 pm – 12:15 pm
Discussion
Marcelo Franken, José Eduardo Krieger, Fernando R. Giugni, Natália Olivetti e José Luiz Pedroso
12:15 pm – 12:45 pm
Satellite Symposium Roche: Personalized healthcare in diagnostic therapies anti-RET
Roberto Carmagnani Pestana – Hospital Israelita Albert Einstein
Vivek Subbiah – MD Anderson Cancer Center Network, Houston, TX
12:45 pm – 01:00 pm
Satellite Symposium Varian – Precision Medicine in Practice
Manuel Coelho
01:00pm – 01:15pm
BREAK
INNOVATION
Fernando Moura – Hospital Israelita Albert Einstein
01:15 pm – 01:30 pm
Innovation and precision medicine
Camila Hernandes – Hospital Israelita Albert Einstein
CITY OF HOPE
Alessandro Igor Cavalcanti Leal – Delfi Diagnostics
01:30 pm – 01:50 pm
IDDV “Integrated Drug Development Venture” – COH’s approach to take selected funding and develop preclinical projects
Janani Krishnamurthy – City of Hope
01:50 pm – 02:10 pm
GPM Manufacturing in an Academic Environmenit
Taby Ahsan – City of Hope
02:10 pm – 02:30 pm
Discussion
Alessandro Leal, Fernando Moura, Juliana Beal, Janani Krishnamurthy e Taby Ahsan
DATA-BASED PRECISION MEDICINE
Edson Amaro Junior – Hospital Israelita Albert Einstein
Leonardo Pinto De Carvalho – Hospital Israelita Albert Einstein
02:30 pm – 02:45 pm
Artificial intelligence and precision medicine
Eduardo Pontes Reis – Hospital Israelita Albert Einstein
02:45 pm – 03:00 pm
Mcode and the unique coding effort for oncology
Zeshan A. Rajput – The MITRE Corporation
03:00 pm – 03:15 pm
The City of Hope Poseidon enterprise-wide platform for real-world data and evidence in cancer
Samir Courdy –City of Hope
03:15 pm – 03:35 pm
Polygenic risk score in the brazilian population
Barbara Bitarello – Bryn Mawr College
03:35 pm – 03:50 pm
Evolution of risk stratification: application and usefulness of more accurate risk scores
Leonardo Pinto de Carvalho – Hospital Israelita Albert Einstein
03:50 pm – 04:05 pm
Discussion
Edson Amaro Junior, Eduardo Pontes Reis, Zeshan A Rajput, Samir Courdy, Barbara Bitarello e Leonardo Pinto De Carvalho
04:05 – pm
Closing Remarks
- 20 de outubro de 2022 | Quinta-feira
- 21 de outubro de 2022 | Sexta-feira
- 22 de outubro de 2022 | Sábado
Time
Activity Moderator/Speaker
08:00 am – 08:15 am
Opening Session
Miguel Cendoroglo – Hospital Israelita Albert Einstein
TUMOR GENOMICS
João Bosco de Oliveira – Hospital Israelita Albert Einstein
08:15 am – 08:35 am
Tumor genomics in clinical practice
Paulo Campregher – Hospital Israelita Albert Einstein
08:35 am – 08:45 am
Discussion
Paulo Campregher e João Bosco de Oliveira
GENOMICS IN PRECISION MEDICINE
João Bosco de Oliveira Filho – Hospital Israelita Albert Einstein
08:45 am – 09:15 am
Genomic and data sharing approaches to uplift discovery in rare disease
Anne O´Donnel – Boston Children’s Hospital and Broad Institute of MIT and Harvard
09:15 am – 09:45 am
Multiomics in the study of rare diseases
João Bosco de Oliveira Filho – Hospital Israelita Albert Einstein
09:45 am – 09:55 am
Discussion
João Bosco de Oliveira Filho e Anne O´Donnel
09:55 am – 10:25 am
BREAK
LIQUID BIOPSY
João Bosco de Oliveira Filho – Hospital Israelita Albert Einstein
10:25 am – 10:40 am
New strategies for cancer screening using liquid biopsy
Alessandro Igor Cavalcanti Leal – Delfi Diagnostics
10:40 am – 10:55 am
Liquid Biopsy
Fernando Moura Silva – Hospital Israelita Albert Einstein
GENOMICS IN PRECISION MEDICINE
João Bosco de Oliveira Filho – Hospital Israelita Albert Einstein
10:55 am – 11:20 am
Universal genomic newborn sequencing?
Robert Green – Harvard Medical School
11:20 am – 11:45 am
CRISPR gene therapy for sickle cell disease
Ricardo Weinlich – Instituto de Ensino e Pesquisa Hospital Albert Einstein
11:45 am – 12:00 pm
Discussion
João Bosco de Oliveira Filho, Robert Green e Ricardo Weinlich
12:00 pm – 12:30 pm
Satellite symposium Astra Zeneca: Precision Medicine in Lung Cancer
Fernando Moura – Hospital Israelita Albert Einstein
12:30 pm – 13:00 pm
BREAK
PHARMACOGENOMICS
João Bosco de Oliveira Filho – Hospital Israelita Albert Einstein
01:05 pm – 01:20 pm
Pharmacogenomics
Luis Izquierdo López – Veritas Genetics
CITY OF HOPE
Alessandro Igor Cavalcanti Leal – Delfi Diagnostics
Fernanda Teresa Lima – Hospital Israelita Albert Einstein
01:20 pm – 01:40 pm
Communicating Genomic Information to Patients & Providers
Stacy W. Gray – City of Hope
01:40 pm – 02:00 pm
Integrating Somatic and Germline Testing for Precision Medicine
Stephen Gruber – City of Hope
02:00 pm – 02:20 pm
Discussion
Alessandro Leal, Stacy W. Gray e Stephen Gruber
HEREDITARY PREDISPOSITION TO CANCER
Fernanda Teresa Lima – Hospital Israelita Albert Einstein
02:20 pm – 02:35 pm
Hereditary pancreatic cancer
Pedro Luiz Serrano Uson Junior – Hospital Israelita Albert Einstein
02:35 pm – 02:50 pm
Lynch syndrome
Stephen Gruber – City of Hope
02:50 pm – 03:05 pm
Ten Genes for Breast Cancer
William Foulkes – McGill University
03:05 pm – 03:20 pm
Hereditary gastric cancer – updates
Carla Oliveira – Bioinf2bio LDA
03:05 pm – 03:20 pm
Hereditary predisposition to cancer in children and adults: differences, intersections and interfaces.
Fernanda Teresa Lima – Hospital Israelita Albert Einstein
03:20 pm – 03:35 pm
Discussion
Fernanda Teresa Lima, Carla Oliveira, Stephen Gruber, Willian Foulkes e Pedro Luiz Serrano Uson Junior
03:35 pm – 04:05 pm
BREAK
PRACTICE IN GENOMIC MEDICINE
Fernanda Teresa Lima – Hospital Israelita Albert Einstein
04:05 pm – 04:20 pm
Genomic medicine skills and competencies
Dhavendra Kumar – William Harvey Research Institute, Bart’s &. The London School of Medicine & Dentistry, Queen Mary University of London, UK
04:20 pm – 04:50 pm
Genomics and Society: Ethical, Legal, Cultural and Socioeconomic Implications
Dhavendra Kumar – William Harvey Research Institute, Bart’s &. The London School of Medicine & Dentistry, Queen Mary University of London, UK
04:50 pm – 05:05 pm
Discussion
Fernanda Teresa Lima, Dhavendra Kumar
GENOMIC MEDICINE IN PEDIATRICS
Fernanda Teresa Lima – Hospital Israelita Albert Einstein
05:05 pm – 05:20 pm
Mutation-specific therapies – the case of cystic fibrosis
Luiz Vicente Ribeiro Ferreira da Silva Filho – Hospital Israelita Albert Einstein
05:20 pm – 05:35 pm
Precision medicine in pediatric sepsis
Daniela Nasu Monteiro Medeiros – Hospital Israelita Albert Einstein
05:35 pm – 05:50 pm
Genomic Medicine in Fetal Medicine
Rita de Cassia Sanchez e Oliveira – Hospital Israelita Albert Einstein
05:50 pm – 06:05 pm
Genomic Neonatal Screening: Where are we and where are we going?
Flavia Balbo Piazzon
06:05 pm – 06:20 pm
Discussion
Fernanda Teresa Lima, Luiz Vicente Ribeiro Ferreira da Silva Filho, Eduardo Juan Troster, Rita de Cassia Sanchez e Oliveira e Flávia Balbo Piazzon
06:20 – pm
Closing Remarks
Time
Activity Moderator/Speaker
CT-DNA in cancer recurrence
Juliana Beal – Hospital Israelita Albert Einstein
08:15 am – 08:30 am
Use of CT-DNA for personalized cancer recurrence testing
Dra. Tiffany Ellis – Natera
ROBOTIC SURGERY
Nam Jin Kim – Hospital Israelita Albert Einstein
08:30 am – 08:45 am
Robotic oncourologic surgery
José Roberto Colombro Junior – Hospital Israelita Albert Einstein
08:45 am – 09:00 am
Robotic oncothoracic surgery
Ricardo Mingarini Terra – Hospital Israelita Albert Einstein
09:00 am – 09:15 am
Robotic oncogynecologic surgery
Renato Moretti Marques – Hospital Israelita Albert Einstein
09:15 am – 09:30 am
Robotic oncogastrointestinal surgery
Sérgio Eduardo Alonso de Araújo – Hospital Israelita Albert Einstein
09:30 am – 09:45 am
Discussion
Nam Jin Kim, José Roberto Colombro Junior, Ricardo Mingarini Terra, Renato Moretti Marques e Sérgio Eduardo Alonso De Araújo
ONCOLOGICAL INTERVENTION AND DIAGNOSTIC MOLECULAR IMAGING
Francisco Leonardo Galastri – Hospital Israelita Albert Einstein
09:45 am – 10:00 am
Interventional radiology in the diagnosis of neoplasms
Guilherme Moratti Gilberto – Hospital Israelita Albert Einstein
10:00 am – 10:15 am
Molecular imaging diagnostic
Guilherme de Carvalho Campos Neto – Hospital Israelita Albert Einstein
10:15 am – 10:30 am
Discussion
Guilherme Moratti Gilberto, Guilherme De Carvalho Campos Neto, Francisco Leonardo Galastri e Fernando Moura
10:30 am – 11:00 am
BREAK
PRECISION MEDICINE IN ONCOTHORACIC AND BREAST
Juliana Beal – Hospital Israelita Albert Einstein
Fernando Moura Silva – Hospital Israelita Albert Einstein
11:00 am – 11:15 am
Precision medicine in lung cancer with molecular changes in EGFR and ALK
Patrícia Taranto – Hospital Israelita Albert Einstein
11:15 am – 11:30 am
Precision medicine in lung cancer: other molecular changes
Fernando Moura Silva – Hospital Israelita Albert Einstein
11:30 am – 11:45 am
The revolution of ADCS in breast cancer
Rafael Aliosha Kaliks Guendelmann – Hospital Israelita Albert Einstein
11:45 am – 12:00 pm
CTDNA in breast cancer: where are we?
Alessandro Igor Cavalcanti Leal – Delfi Diagnostics
12:00 pm – 12:15 pm
Discussion
Fernando Moura Silva, Rafael Aliosha Kaliks Guendelmanns e Alessandro Igor Cavalcanti Leal
12:15 pm – 12:45 pm
Satellite Symposium Roche: Personalized Healthcare in Early Stage Non-Small Cell Lung Cancer
Gustavo Schwartzman – Hospital Israelita Albert Einstein
12:45 pm – 01:15 pm
BREAK
PRECISION MEDICINE IN HEMATOLOGY
Nelson Hamerschlak – Hospital Israelita Albert Einstein
01:15 pm – 01:30 pm
Multiple myeloma
Mariana Nassif Kerbauy – Hospital Israelita Albert Einstein
01:30 pm – 01:45 pm
Lymphomas
Guilherme Fleury Perini – Hospital Israelita Albert Einstein
01:45 pm – 02:00 pm
Myeloide diseases
Fábio Pires de Souza Santos – Hospital Israelita Albert Einstein
02:00 pm – 02:15 pm
Bone marrow transplantation
Andreza Alice Feitosa Ribeiro – Hospital Israelita Albert Einstein
02:15 pm – 02:30 pm
Discussion
Nelson Hamerschlak, Mariana Nassif Kerbauy, Guilherme Fleury Perini, Fabio Pires de Souza Santos e Andreza Alice Feitosa Ribeiro
PRECISION MEDICINE IN ONCOGASTROENTEROLOGY, MELANOMA AND AGNOSTIC THERAPIES
Pedro Luiz Serrano Uson Junior – Hospital Israelita Albert Einstein
02:30 pm – 02:45 pm
Precision medicine in melanoma
Gustavo Schvartsman – Hospital Israelita Albert Einstein
02:45 pm – 03:00 pm
Development of biomarker-directed tissue-agnostic drugs
Roberto Carmagnani Pestana – Hospital Israelita Albert Einstein
03:00 pm – 03:15 pm
Precision medicine in colorectal cancer
Pedro Luiz Serrano Uson Junior – Hospital Israelita Albert Einstein
03:15 pm – 03:35 pm
Precision medicine in digestive system tumors
Tanios S. Bekaii-Saab – Mayo Clinic (ASCO)
03:30 pm – 03:50 pm
Discussion
Roberto Carmagnani Pestana, Gustavo Schwartzman, Pedro Luiz Serrano Uson Junior e Tanios S. Bekaii-Saab
03:50 pm – 04:20 pm
BREAK
PRECISION MEDICINE IN URO AND ONCOGYNECOLOGY
Juliana Beal – Hospital Israelita Albert Einstein
04:20 pm – 04:40 pm
Precision medicine in prostate cancer
Oren Smaletz – Hospital Israelita Albert Einstein
04:40 pm – 04:55 pm
PET-PSMA indications
Marcelo Livorsi da Cunha – Hospital Israelita Albert Einstein
04:55 pm – 05:10 pm
Discussion
Oren Smaletz, Fernando Moura e Marcelo Livorsi da Cunha
Precision Medicine In Oncogynecology
Juliana Beal
05:10 pm – 05:25 pm
Precision medicine in oncoginecology
Donato Callegaro Filho
RADIOTHERAPY, THERAPEUTIC ONCOLOGICAL INTERVENTION AND THERANOSTIC
Fernando Moura Silva – Hospital Israelita Albert Einstein
05:25 pm – 05:40 pm
Precision radiotherapy
Eduardo Weltman – Hospital Israelita Albert Einstein
05:40 pm – 05:55 pm
Interventional radiology in the therapeutic approach to neoplastic lesions
Adalberto Batalha Megale – Hospital Israelita Albert Einstein
05:55 pm – 06:10 pm
Teranotic molecular image
Lilian Yuri Itaya Yamaga – Hospital Israelita Albert Einstein
06:10 pm – 06:25 pm
Discussion
Eduardo Weltman, Fernando Moura Silva, Adalberto Batalha Megale e Lilian Yuri Itaya Yamaga
06:25 – pm
Closing Remarks
Time
Activity Moderator/Speaker
Pathology and Precision Medicine
Juliana Beal – Hospital Israelita Albert Einstein
08:15 am – 08:30 am
Pathology and Precision Medicine
Henrique Moura De Paula – Hospital Israelita Albert Einstein
CELL AND GENE THERAPY
José Mauro Kutner – Hospital Israelita Albert Einstein
08:45 am – 09:00 am
Main studies in cell and gene therapy in development at HIAE
José Mauro Kutner – Hospital Israelita Albert Einstein
09:00 am – 09:15 am
The therapeutic potential of extracellular vesicles in the treatment of intervertebral disc degeneration
Pedro Henrique Isoldi Pohl – Hospital Israelita Albert Einstein
09:00 am – 09:15 am
Gene therapy
Linus Pauling Fascina – Hospital Israelita Albert Einstein
09:15 am – 09:30 am
Car-Nk cell therapy
Lucila Nassif Kerbauy – Hospital Israelita Albert Einstein
09:30 am – 09:45 am
Discussion
José Mauro Kutner, Mário Lenza, Linus Pauling Fascina, Lucila Nassif Kerbauy e Pedro Henrique Isoldi Pohl
Metagenomics
Juliana Beal – Hospital Israelita Albert Einstein
09:45am – 10:00am
Liquor Precision Medicine
Gustavo Bruniera Peres Fernandes – Hospital Israelita Albert Einstein
10:00am – 10:15am
BREAK
IMMUNOTHERAPY
Kenneth J Gollob
10:15 am – 10:30 am
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with Anti-Pd-1
John Anthony McCulloch – National Institutes of Health, National Cancer Institute, Bethesda, USA
10:30 am – 10:45 am
Systemic immunological biomarkers determining the benefits of checkpoint inhibitor therapy
Kenneth J Gollob – Hospital Israelita Albert Einstein
10:45 am – 11:00 am
Tumor Mutation Burden as biomarker for immunotherapy in Non-small Cell Lung Cancer
Vamsi Velcheti – NYU Grossman School of Medicine
11:00 am – 11:15 am
Discussion
Kenneth J Gollob, John Mcculloch e Vamsi Velcheti
CARDIO AND NEUROGENETICS
Marcelo Franken – Hospital Israelita Albert Einstein
José Eduardo Krieger – Hospital Israelita Albert Einstein
11:15 am – 11:30 am
When to “think genetic testing” in dyslipidemic patients?
Fernando Rabioglio Giugni – InCor HC-FMUSP
11:30 am – 11:45 am
When do rhythm disorders and cardiomyopathies meet and which genetic tests should be considered?
Natália Olivetti – InCor HC-FMUSP
11:45 am – 12:00 pm
How to proceed if the result of the genetic test is a VUS?
José Luiz Pedroso – Hospital Israelita Albert Einstein
12:00 pm – 12:15 pm
Discussion
Marcelo Franken, José Eduardo Krieger, Fernando R. Giugni, Natália Olivetti e José Luiz Pedroso
12:15 pm – 12:45 pm
Satellite Symposium Roche: Personalized healthcare in diagnostic therapies anti-RET
Roberto Carmagnani Pestana – Hospital Israelita Albert Einstein
Vivek Subbiah – MD Anderson Cancer Center Network, Houston, TX
12:45 pm – 01:00 pm
Satellite Symposium Varian – Precision Medicine in Practice
Manuel Coelho
01:00pm – 01:15pm
BREAK
INNOVATION
Fernando Moura – Hospital Israelita Albert Einstein
01:15 pm – 01:30 pm
Innovation and precision medicine
Camila Hernandes – Hospital Israelita Albert Einstein
CITY OF HOPE
Alessandro Igor Cavalcanti Leal – Delfi Diagnostics
01:30 pm – 01:50 pm
IDDV “Integrated Drug Development Venture” – COH’s approach to take selected funding and develop preclinical projects
Janani Krishnamurthy – City of Hope
01:50 pm – 02:10 pm
GPM Manufacturing in an Academic Environmenit
Taby Ahsan – City of Hope
02:10 pm – 02:30 pm
Discussion
Alessandro Leal, Fernando Moura, Juliana Beal, Janani Krishnamurthy e Taby Ahsan
02:15 pm – 02:30 pm
Discussion
DATA-BASED PRECISION MEDICINE
Edson Amaro Junior – Hospital Israelita Albert Einstein
Leonardo Pinto De Carvalho – Hospital Israelita Albert Einstein
02:30 pm – 02:45 pm
Artificial intelligence and precision medicine
Eduardo Pontes Reis – Hospital Israelita Albert Einstein
02:45 pm – 03:00 pm
Mcode and the unique coding effort for oncology
Zeshan A. Rajput – The MITRE Corporation
03:00 pm – 03:15 pm
The City of Hope Poseidon enterprise-wide platform for real-world data and evidence in cancer
Samir Courdy – City of Hope
03:15 pm – 03:35 pm
Polygenic risk score in the brazilian population
Barbara Bitarello – Bryn Mawr College
03:35 pm – 03:50 pm
Evolution of risk stratification: application and usefulness of more accurate risk scores
Leonardo Pinto de Carvalho – Hospital Israelita Albert Einstein
03:50 pm – 04:05 pm
Discussion
Edson Amaro Junior, Eduardo Pontes Reis, Zeshan A Rajput, Samir Courdy, Barbara Bitarello e Leonardo Pinto De Carvalho
04:05 – pm
Closing Remarks
INTERNATIONAL SPEAKERS
Anne O'Donnell-Luria is an Assistant Professor and Clinical Genetics Attending Physician at Boston Children’s Hospital and Harvard Medical School. She is a co-director of the Center for Mendelian Genomics at the Broad Institute of MIT and Harvard. Her research focuses on increasing the rate of rare disease diagnosis and discovery with resources like gnomAD, AnVIL, and participating in ClinGen.
Dr. Bitarello obtained her undergraduate degree in Biology at UNICAMP and graduate degrees in Genetics and Evolutionary Biology at USP. As a Ph.D. student, she spent a year at the Max Planck Institute for Evolutionary Anthropology in Germany, where she developed a novel statistical method to detect signatures of long-term balancing selection in human genomes—which was awarded Best Graduate Student Paper in 2019 by the Society for Molecular Biology and Evolution. She pursued a first postdoc at the Max Planck Institute and the second one at the University of Pennsylvania. There, she applied her evolutionary background to biomedical data, focusing on the possibilities and challenges involved with using polygenic risk scores (PRS) in admixed populations.
Medically qualified accredited genetic and genomic clinician (UK & USA) with special interests in clinical genetics and genomic medicine. He is credited with landmark contributions and achievements in genetic/ inherited rare diseases of children, hereditary familial conditions of heart and blood vessels, genomic education and training, applications of novel genomic principles and technology in genomic & precision medicine including preventive public and population health genomics.
An expert in the fields of immunology, adoptive immunotherapy and neuroimmunology, Dr Janani Krishnamurthy received her PhD at MD Anderson Cancer Center enjoyed working at bluebird bio, TCR2 Therapeutics and Atara Biotherapeutics before taking on her current role as Director for leading drug development initiatives at City of Hope
John McCulloch is currently Staff Scientist at the Trinchieri Lab at the National Cancer Institute, National Institutes of Health in Bethesda, USA, where he develops novel bioinformatics
methods for investigating the role of the host microbiome on cancer treatment outcomes. He
graduated in Pharmacy in 1999 and obtained a PhD in Clinical Microbiology in 2006 both at the
University of São Paulo.
methods for investigating the role of the host microbiome on cancer treatment outcomes. He
graduated in Pharmacy in 1999 and obtained a PhD in Clinical Microbiology in 2006 both at the
University of São Paulo.
Doctor of Medicine and Surgery; Extraordinary Doctorate Award from the UCM (Universidad Complutense de Madrid) ; Master of Science in Medical Genetics from the University of Glasgow; Medical Genetics Chief of Services in the main University Hospitals in Madrid.
Robert C. Green (MD, MPH) leads the Preventive Genomics Clinic, the Genomes2People Research Program, and the Population Health Precision Initiative at Mass General Brigham, the Broad Institute, Ariadne Labs, and Harvard Medical School. His work has provided initial data on the clinical utility and cost-effectiveness of genomic sequencing in healthy adults (the MedSeq Project), in active duty military personnel (the MilSeq Project), and most recently in healthy newborns (the BabySeq Project).
Dr. Green also leads a genomic feedback policy for research participants within the Global Alliance for Genomics and Health, Verily-Google Baseline Project, and the All of Us Research Program.
Dr. Green also leads a genomic feedback policy for research participants within the Global Alliance for Genomics and Health, Verily-Google Baseline Project, and the All of Us Research Program.
Samir has very diverse background in computer science and software engineering. His breadth of expertise, training, and knowledge serves him well in ensuring the successful implementation of this multi-institution research collaboration. Samir is responsible for aspects of software development, and implementation of real world solutions focused on the delivery of precision medicine solutions powered by real world data and evidence. To that end, developing integrated solutions for clinical, translational, basic, and population sciences research has been part of what he has delivered on for the last 24 years serving as Chief Research Informatics Officer at NCI designated comprehensive cancer centers. For the past 4 years, this experience has served him well in doing so at the City of Hope Comprehensive Cancer Center. He serves as the Senior Vice President for Informatics leading the Center For Informatics. I work very closely with the members of the Executive Leadership, members of the Senior Leadership, Research and Clinical Faculty to develop strategic plans to meet the growing needs of the organization with a focus on supporting the needs of the Cancer Center and RWD&E for precision medicine and research. He aims to meet the needs and requirements of the Cancer Center, provide guidance and plan effort, run coordination meetings, manage staff, and provide strategic direction for design, architecture, projects, and technology. Samir oversees clinical, basic, translational, and population science research applications, database development, high performance computing and translational bioinformatics to support principal investigators in their research. To that end, he incepted the design and architecture for the POSEIDON data lake and research platform. This solution provides tools for cohort exploration, data visualization, capabilities and environments for machine learning, and artificial intelligence as well as providing an intra/extra mural collaboration platform
Dr. Gray is an Associate Professor at the City of Hope Comprehensive Cancer Center and the Beckman Research Institute, the Deputy Director for the City of Hope Center for Precision Medicine, and the Division Chief of Clinical Cancer Genomics. Dr. Gray conducts translational genomics research, evaluating issues at the intersection of oncology, genomics and health communication. Her overall goal is to gain a better understanding of how a variety of factors work to drive the use of new genomic technologies and design targeted interventions to improve the delivery of personalized cancer care.
An internationally recognized cancer geneticist and oncologist, Stephen Gruber, M.D., Ph.D., M.P.H., is a physician-scientist who focuses his clinical practice and research program on precision medicine and the genomics of cancer in order to improve treatment and care for cancer patients and their families. Dr. Gruber is an expert in Lynch syndrome and hereditary susceptibility to colorectal cancer, and he has broad experience in the care of patients and families with inherited susceptibility to cancer.
Dr. Gruber leads the Center for Precision Medicine at City of Hope. Precision medicine uses genomic-driven insights, clinical expertise, and advanced analytics to pioneer personalized prevention and treatment plans to transform the outcomes and quality of life for patients, their families and the community. His research program focuses on the genetic epidemiology of cancer, with an emphasis on colorectal cancer, melanoma and other solid tumors, bringing clinical cancer genetics and translational research to cancer prevention.
Dr. Gruber leads the Center for Precision Medicine at City of Hope. Precision medicine uses genomic-driven insights, clinical expertise, and advanced analytics to pioneer personalized prevention and treatment plans to transform the outcomes and quality of life for patients, their families and the community. His research program focuses on the genetic epidemiology of cancer, with an emphasis on colorectal cancer, melanoma and other solid tumors, bringing clinical cancer genetics and translational research to cancer prevention.
Dr. Taby Ahsan is currently Vice President of Cell and Gene Therapy Operations at City of Hope, Inc. She has over 20 years of experience in both basic research and translation of cell-based products in the fields of tissue engineering, regenerative medicine and immunotherapy. Taby is also a Member of the Cell, Tissue, and Gene Therapy Advisory Council (CTGTAC) at the FDA.
Tanios Bekaii-Saab is a Professor of Medicine at the Mayo Clinic College of Medicine and Science, Leader of the Gastrointestinal Cancer Program at the Mayo Clinic Cancer Center, Chair for Medical Oncology for the Division of Hematology/Oncology at Mayo Clinic in Arizona, USA. He is the consortium chair for the ACCRU research Network. Dr Bekaii-Saab has authored or co-authored more than 450 peer reviewed publications, abstracts, and book chapters.
An oncology specialist with clinical, translational, and basic research experience. Highly personable with the ability to effectively lead and motivate teams to increase productivity, efficiently meet project deliverables, and achieve strategic goals. More than a decade of experience as a scientist educator, bridging scientific communication gaps by translating complex information to make it accessible and understandable.
Greatest strengths lie in relationship building, learning and strategic thinking, and influencing.
Greatest strengths lie in relationship building, learning and strategic thinking, and influencing.
Dr. Vivek Subbiah is an Associate professor in the Department of Investigational Cancer Therapeutics, the Center Clinical Medical Director of the Clinical Center for Targeted Therapy and Executive Director, Medical Oncology Research, MD Anderson Cancer Network. He serves as the Principal Investigator in over 50 Phase I/II trials. His research interests are drug development in rare cancers and is a major advocate for precision oncology. He has led several first-in-human, and practice changing clinical trials that have led to US FDA approval, EMA approval and in multiple countries eg. Dabrafenib+ trametinib for anaplastic thyroid cancer, vemurafenib for erdheim-chester disease, lurbinectedin for small cell lung cancer, selpercatinib and pralsetinib for RET positive non-small cell lung cancer and RET positive medullary and RET fusion positive thyroid cancers, and Dabrafenib+ Trametinib tissue agnostic approval. His trial portfolio includes several tissue agnostic and basket trials trials that target BRAF,MEK,RET,CDK,WNT,VEGF,mTOR,EZH2-EED pathways, novel immunotherapy combination trials GITR,TLR7/9,PD1,WT1, several first in human antibody drug conjugates and radiopharmaceuticals. He has published over 250 peer-reviewed in several prestigious journals such as The New England Journal of Medicine, Nature Medicine, Journal of Clinical Oncology, JAMA Oncology, Cancer Discovery, Lancet Oncology, Nature Reviews Clinical Oncology, Lancet Diabetes and Endocrinology and Clinical Cancer Research. He is in the editorial board of several prestigious journals. He is the recipient of NIH R01 funding and has received many awards including Andrew Sabin Family fellowship for 2021-2022, The Emil Frei III Award for Translational Research 2021. Dr. Subbiah is active on Twitter and has more than 20 K followers @VivekSubbiah
Dr. Zeshan A. Rajput is an internist and informaticist. He is the group lead of MITRE’s Open Science Group in the Clinical Insights Innovation Cell, the Chief Clinical Lead of MITRE’s Oncology Standard Health Record project, and the Project Lead of MITRE’s Clinical Insights Platform. Zeshan lives with his wife and two daughters aboard the motor vessel Heart Beat, a 47 foot Nordhavn trawler currently on the eastern seaboard of the United States.
NATIONAL SPEAKERS
Vascular Surgery - Hospital Israelita Albert Einstein
Interventionist Radiology and Endovascular Surgery - Hospital Israelita Albert Einstein.
Interventionist Radiology and Endovascular Surgery - Hospital Israelita Albert Einstein.
Associate Professor - Johns Hopkins School of Medicine (Baltimore, USA). Medical Director - Delfi Diagnostics, Inc.
Physician at the Hematology and Bone Marrow Transplantation (BMT) Service at Hospital Israelita Albert Einstein (HIAE). Medical Coordinator of the BMT unit at Hospital Brasil, Rede D'or.
Graduated in Biotechnology, Master and Doctor in Biotechnology applied to health. Author of several works in Biotechnology and new technologies in health. Mentor of the mentoring program at Eretz.bio, startup incubator at Hospital Israelita Albert Einstein. Former entrepreneur and head of Innovation and Partnerships with Startups at the Innovation Board of Hospital Israelita Albert Einstein.
MD, Neuroradiologist at Hospital Israelita Albert Einstein. Superintendent of Data Science and Big Data Analytics at Hospital Israelita Albert Einstein. Associate Professor at the Radiology Department of the University of São Paulo Medical School. Full Professor at the Albert Einstein School of Health Sciences.
Residency at the University of São Paulo School of Medicine. Master's degree from the Pediatrics Discipline at the University of São Paulo School of Medicine. PhD from the Department of Radiology at the University of São Paulo School of Medicine. Specialist in Radio-Oncology from the Brazilian College of Radiology - Brazilian Society of Radiotherapy. Specialist in Oncology from the Brazilian Society of Cancerology. International Specializations: Pediatric Oncology, Pediatric Radiotherapy - St. Jude Children's Research Hospital. President of the Brazilian Society of Radiotherapy (2014 - 2017). PhD Professor of Radiotherapy at the University of São Paulo School of Medicine. Medical coordinator of the radiotherapy service at Hospital Israelita Albert Einstein. Areas of major interest: Neuro-oncology, pediatric oncology, radiosurgery, urological tumors.
Graduated in Medicine from the University of São Paulo (2002). He did his residency in hematology at the Hospital das Clínicas of the Medical School of the University of São Paulo from 2005-2007. He was a visiting physician at the Leukemia Department of the M.D. Anderson Cancer Center at the University of Texas in 2004 and 2007. He held a clinical specialization fellowship in Leukemias, Myeloproliferations and Myelodysplastic Syndromes at the Leukemias Department of M.D. Anderson Cancer Center from 2008-2009. He is currently a hematologist at the Hospital Israelita Albert Einstein and Hospital Beneficência Portuguesa in São Paulo.
Clinical Geneticist at the Genetic Counseling Center of Hospital Israelita Albert Einstein (HIAE). Medical Clinical Geneticist responsible for the Oncogenetics Sector of the Mastology Discipline of the Gynecology Department of UNIFESP-EPM. Medical Clinical Geneticist responsible for the Oncogenetics Outpatient Clinic of the IOP-GRAACC-UNIFESP. Professor at the Albert Einstein Israelita School of Health Sciences. Clinical Geneticist by the Brazilian Medical Association. Master of Science from UNIFESP-EPM. Doctorate in Science from UNIFESP-EPM. Specialist in Health Education from UNIFESP-EPM. Specialist in Health Education and Continuing/Permanent Health Education by HIAE. Lean Belt Certification by HIAE and Seta Management Development.
Graduated in Medicine from the Pontifícia Universidade Católica de Campinas (1999). Specialist in Clinical Oncology from the Brazilian Institute of Cancer Control (2004). He has experience in Medicine, Clinical Oncology, and Clinical Research. PhD in Sciences by the Heart Institute of the Medical Sciences School of the University of São Paulo - USP. Focus area: Pulmonary Neoplasms. Clinical Oncologist at the Família Dayan-Daycoval Hematology and Oncology Center, Hospital Israelita Albert Einstein.
Graduation in Medicine at the University of São Paulo Medical School (FMUSP).
Residency in Internal Medicine at Hospital das Clínicas (HC) of the FMUSP.
Residency in Cardiology at InCor HC-FMUSP
Physician at the Center of Precision Medicine in Cardiology of InCor HC-FMUSP.
Residency in Internal Medicine at Hospital das Clínicas (HC) of the FMUSP.
Residency in Cardiology at InCor HC-FMUSP
Physician at the Center of Precision Medicine in Cardiology of InCor HC-FMUSP.
Pediatrician and Geneticist by UNIFESP. PhD in Pathology and Genetics from FMUSP. He worked 9 years with extended neonatal screening at Instituto Jo Clemente and with genetic newborn screening at Mendelics Genomic Analysis. She is currently a postdoctoral researcher at the Université de Liège, Belgium for the implementation of the "BabyDetect Project" - the first universal genetic neonatal screening.
Interventional Radiologist at the Interventional Medicine Center of the Hospital Israelita Albert Einstein and at the Oncological Intervention Center of the Brazilian Institute for Cancer Control. He is a full member of the Brazilian Society of Interventionist Radiology and Endovascular Surgery and a PhD in Health Sciences from the Albert Einstein School of Health Sciences.
Graduated in Medicine from Universidade Estadual Paulista Júlio de Mesquita Filho (1999). Medical Residency at the University of São Paulo (2002). Nuclear Physician at Hospital Israelita Albert Einstein.
Hematologist at Hospital Israelita Albert Einstein. Coordinator of the Lymphoma Outpatient Clinic at the Vila Santa Catarina Municipal Hospital. Coordinator of Onco-Hematology of Grupo Américas.
Graduated in Medicine from the Federal University of Minas Gerais (2013). Residency in radiology and diagnostic imaging at the Santa Casa de Misericórdia Foundation of Belo Horizonte and specialization in interventional radiology and endovascular surgery at the Hospital Israelita Albert Einstein. He is part of the interventional radiology team at Hospital Israelita Albert Einstein, Hospital 9 de Julho, and Hospital Paulistano.
Clinical oncologist graduated from The University of Texas MD Anderson Cancer Center. He has a medical degree and a residency in Internal Medicine, both from the Escola Paulista de Medicina/Universidade Federal de São Paulo, and a doctorate from the Hospital Israelita Albert Einstein. He is currently an oncologist at Hospital Israelita Albert Einstein, a Medical Residency Preceptor, and a professor of the post-graduate oncology course at Hospital Israelita Albert Einstein.
Medical residency in Clinical Pathology/Laboratory Medicine at EPM/UNIFESP. Medical residency in Pathology at the Faculty of Medicine/University of São Paulo. PhD in Pathology from the Faculty of Medicine/University of São Paulo. Visiting Fellowship Hematopathology Department/MD Anderson Cancer Center and Adjunct Professor at the Faculty of Medicine/Federal University of Goiás.
Director of Genomika-Einstein Laboratory.
Physician graduated from the Federal University of Pernambuco, with residency in Internal Medicine from the same institution.
Post-doctoral fellowship in Clinical Laboratory Immunology at NIH.
PhD in Clinical Pathology from the University of São Paulo.
PhD in Experimental Immunology from the University of Amsterdam.
Previously served as clinical physician and co-director of immunology at the Department of Laboratory Medicine, NIH.
Physician graduated from the Federal University of Pernambuco, with residency in Internal Medicine from the same institution.
Post-doctoral fellowship in Clinical Laboratory Immunology at NIH.
PhD in Clinical Pathology from the University of São Paulo.
PhD in Experimental Immunology from the University of Amsterdam.
Previously served as clinical physician and co-director of immunology at the Department of Laboratory Medicine, NIH.
Full Professor of Genetics and Molecular Medicine at the University of São Paulo Medical School (USP), where he is also director of the Laboratory of Genetics and Molecular Cardiology of the Heart Institute, Hospital das Clínicas (Incor/HC-FMUSP). Graduated from the USP's Ribeirão Preto School of Medicine (1984), PhD in physiology from the Medical College of Wisconsin (1988), post-doctorate in molecular biology from Harvard University (1990) and Stanford University (1992), and lecturer at USP (1996). He is a member of the Brazilian Academy of Sciences and the Academy of Sciences of the State of São Paulo, and was pro-rector of Research at USP (2014-2017). His research focuses on the identification and characterization of genetic determinants and the development of new therapeutic strategies for cardiovascular diseases.
Associate Professor, Department of Neurology, Universidade Federal de São Paulo / Escola Paulista de Medicina (UNIFESP/EPM)
Vice Coordinator of the General Neurology and Ataxias Section of the Universidade Federal de São Paulo (UNIFESP).
Vice Coordinator of the General Neurology and Ataxias Section of the Universidade Federal de São Paulo (UNIFESP).
Medical Manager of the Hemotherapy and Cellular Therapy Department at Hospital Israelita Albert Einstein (HIAE). Associate Professor at Fac de Ciencias da Saude FICSAE. PhD in Hematology from the University of São Paulo Medical School. Former fellow of the New York Blood Center.
PhD in Sciences from the University of São Paulo Medical School, member of the Brazilian Society of Urology, International Member of the American Urological Association, Proctor in Robotic Surgery at Hospital Israelita Albert Einstein.
Clinical Oncologist at Albert Einstein Hospital and Physician in the Precision Medicine Group
Senior Scientist and Director of the Center for Research in Immuno-oncology (CRIO) at Hospital Israelita Albert Einstein in Sao Paulo. He obtained his PhD in Immunology from the University of Colorado Medical Center and the National Jewish Center for Respiratory Medicine in Denver, Colorado, and his postdoctoral training at DNAX Research Institute in Palo Alto, California. He was a visiting Associate Professor at Stanford University School of Medicine and a Visiting Researcher at the National Cancer Institute, the National Institutes of Health in the United States. His research focuses on the discovery of biomarkers and immune mechanisms behind therapeutic responses in cancer and infectious diseases.
Professor at the Department of Cardiopulmonology of the University of São Paulo medical School.
Post-doctorate and fellow in interventional cardiology at the national university of Singapore.
PhD in molecular biology by Federal University of São Paulo (UNIFESP).
PhD in cardiology from the University of Utrecht.
Day-time physician at the ICU of Hospital Israelita Albert Einstein.
Post-doctorate and fellow in interventional cardiology at the national university of Singapore.
PhD in molecular biology by Federal University of São Paulo (UNIFESP).
PhD in cardiology from the University of Utrecht.
Day-time physician at the ICU of Hospital Israelita Albert Einstein.
Graduated in Medicine from the University of São Paulo Medical School. She holds a master's degree and a doctorate in Radiology from the University of São Paulo School of Medicine.
Manager of the Maternal and Child Department at Hospital Israelita Albert Einstein (HIAE). PhD in Business Administration from EAESP- FGV. Master in Pediatrics by Federal University of São Paulo - Escola Paulista de Medicina (UNIFESP-EPM).
Resident in Hematology at Hospital das Clínicas, University of São Paulo, Resident in Bone Marrow Transplantation at Hospital Israelita Albert Einstein, Post-doctoral fellow in Cellular Therapy at MD Anderson Cancer Center, Houston, USA.
Full Professor at the Pediatrics Department of the University of São Paulo Medical School (FMUSP). Assistant Physician at the Pulmonology Unit of the Children's Institute of HCFMUSP and Pediatric Pulmonologist at HIAE.
Graduated in Medicine from the University of São Paulo (2000). Residency in clinical medicine at HC-FMUSP and cardiology at InCor - HC-FMUSP. Specialist in clinical medicine (2003), cardiology (2005) and intensive care (2007). He holds a PhD in Cardiology from the University of São Paulo School of Medicine (2016). He is currently a Medical Manager of Cardiology and Organizer of the Cardiology Scientific Meetings.
Nuclear Physician at the Service of Nuclear Medicine and PET/CT at HIAE.
Specialist in Nuclear Medicine by the Brazilian College of Radiology and Brazilian Society of Nuclear Medicine.
Specialist in Nuclear Medicine by the Brazilian College of Radiology and Brazilian Society of Nuclear Medicine.
Hematologist and Residency Preceptor in Bone Marrow Transplantation at Hospital Israelita Albert Einstein.
Especialista em oncologia com experiência clínica, translacional e pesquisa básica. Estilo de liderança altamente personalizado com grande capacidade de liderar e motivar equipes para aumentar a produtividade, atender com eficiência os resultados dos projetos e atingir metas estratégicas. Mais de uma década de experiência como educadora na área científica, preenchendo lacunas na comunicação científica através da tradução de informações complexas para torná-las acessíveis e compreensíveis.
Os principais diferenciais estão na sua capacidade de construir relacionamentos, no seu conhecimento e pensamento estratégico, e na sua força para influenciar.
Os principais diferenciais estão na sua capacidade de construir relacionamentos, no seu conhecimento e pensamento estratégico, e na sua força para influenciar.
Dr Natália Olivetti, PhD candidate in Genetics and Arrhythmogenic Myocardiopathies at the University of São Paulo Medical School (FMUSP); Residency in Cardiology at FMUSP/ InCor.
Specialization in Clinical Arrhythmia at FMUSP/Incor; Residency in Internal Medicine at UERJ/ HUPE;
Medical School at the Universidade Federal Fluminense.
Specialization in Clinical Arrhythmia at FMUSP/Incor; Residency in Internal Medicine at UERJ/ HUPE;
Medical School at the Universidade Federal Fluminense.
Associate Professor at the University of São Paulo School of Medicine | Full Professor at the Albert Einstein Israelita School of Health Sciences | Coordinator of the Hematology and Bone Marrow Transplantation Program at the Hospital Israelita Albert Einstein.
He has a degree in Medicine from the University of São Paulo Medical School (FMUSP) (1995), with residency in Internal Medicine at the Hospital das Clínicas- FMUSP (1996-1998) and a specialization in Clinical Oncology at Memorial Sloan Kettering Cancer Center in New York (1999-2002). He is currently a clinical oncologist at Hospital Israelita Albert Einstein.
Clinical Oncologist at Hospital Israelita Albert Einstein, at the Precision Medicine Program at Hospital Israelita Albert Einstein and at Hospital Municipal Vila Santa Catarina
Clinical Pathologist and Hematologist. PhD in Clinical Pathology from the State University of Campinas (UNICAMP). Post-doctorate in Immunology at Fred Hutchinson Cancer Research Center and Former Associate Researcher at Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Former Medical Director of Foundation Medicine in Brazil, Cambridge, MT, USA. Member of the Molecular Medicine Committee of the Brazilian Society of Clinical Pathology and of the Brazilian Society of Bone Marrow Transplantation. He is currently responsible for cancer genomics testing at the laboratory of diagnostic medicine and a researcher at the Teaching and Research Institute of the Hospital Israelita Albert Einstein.
MD, Specialist in Spinal Diseases, PhD from FMABC and University of Pittsburgh. His line of research focuses on the treatment of diseases related to spine degeneration and the regenerative potential of microvesicles derived from mesenchymal stem cells.
Medical oncologist with a fellowship at the Mayo Clinic, Phoenix, Arizona, in the area of gastrointestinal tumors. He currently works as a clinical oncologist at Hospital Israelita Albert Einstein, Hospital Municipal Vila Santa Catarina and at Rede Einstein of Oncology and Hematology.
Clinical Oncologist at Hospital Israelita Albert Einstein and Supervisor of the residency program in clinical oncology at Hospital Israelita Albert Einstein.
Coordinator of the Gynecological Oncology Service of the Vila Santa Catarina Teaching Hospital of the Sociedade Beneficente Israelita Brasileira Albert Einstein and of the Post Graduate Program in Robotic Surgery in Gynecology of the Hospital Israelita Albert Einstein. PhD from the Gynecological Oncology Discipline of the Escola Paulista de Medicina of the Federal University of São Paulo.
Associate Professor of the Thoracic Surgery Discipline at the University of São Paulo (USP).
Head of the Service of Thoracic Surgery of the Cancer Institute of the State of São Paulo (ICESP).
Scientific Director of the Brazilian Society of Thoracic Surgery (SBCT).
Head of the Service of Thoracic Surgery of the Cancer Institute of the State of São Paulo (ICESP).
Scientific Director of the Brazilian Society of Thoracic Surgery (SBCT).
PhD from the Department of Immunology of the Institute of Biomedical Sciences at the University of São Paulo. He did postdoctoral research at St. Jude's Children's Research Hospital, Memphis (USA) under the supervision of Dr. Douglas Green. He is currently a researcher at the Israelite Institute for Teaching and Research of HIAE, with lines of research in cell death and gene therapy.
Obstetrician and Gynecologist graduated from the University of São Paulo Medical School (FMUSP). Specialist in Fetal Medicine by the Brazilian Medical Association (AMB). PhD in Medicine from (FMUSP). MBA in Health Economics and Management by Escola Paulista de Medicina (UNIFESP). Specialist in Healthcare Improvement from the Institute for Healthcare Improvement. Professor at the Albert Einstein Israelita School of Health Sciences and Medical Coordinator of Fetal Medicine at the Albert Einstein Israelita Hospital.
Physician at the Einstein Familia Dayan Oncology and Hematology Center - Daycoval Clinical Oncology Fellowship at MD Anderson Cancer Center.
Medical Director at the Oncology Center of Hospital israelita Albert Einstein (HIAE).
Coloproctologist surgeon.
President-elect of the Brazilian Society of Coloproctology.
Coloproctologist surgeon.
President-elect of the Brazilian Society of Coloproctology.
ORGANIZING COMITTEE
Fernando Moura
João Bosco de Oliveira Filho
Juliana Aparecida Soares
João Bosco de Oliveira Filho
Juliana Aparecida Soares
SCIENTIFIC COMMITTEE
Alessandro Leal
Camila Hernandes
Edson Amaro Junior
Eduardo Weltman
Elias Knobel
Fernanda Teresa De Lima
Fernando Cotait Maluf
Fernando Moura
Gustavo Schwartzman
Henrique de Paula
Jairo Wagner
João Bosco de Oliveira Filho
José Eduardo Krieger
Jose Mauro Kutner
Juliana Aparecida Soares
Kenneth Gollob
Leonardo Pinto de Carvalho
Linus Pauling Fascina
Marcelo Franken
Mario Lenza
Nam Jin Kim
Nelson Hamerschlak
Oren Smaletz
Rafael Kaliks
Roberto Pestana
Rodrigo Gobbo Garcia
Sérgio Eduardo Alonso Araújo
ORGANIZATION
Centro de Educação em Saúde Abram Szajman do Instituto Israelita de Ensino e Pesquisa Albert Einstein.
SPONSORSHIP
Premium Sponsorship
Premium Sponsorship
Support
Institucional Support
Copyright © 2020 Hospital Israelita Albert Einstein. Todos os direitos reservados.